fotemustine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canteras-Jordana, M; Rodriguez-Vicente, J; Vicente-Ortega, V | 1 |
| Breen, M; Briggs, M; Campbell, DB; Devereux, K; Edwards, FE; Gray, AJ; Ings, RM; Lucas, C; Robinson, BV | 1 |
2 other study(ies) available for fotemustine and B16 Melanoma
| Article | Year |
|---|---|
The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines.
Topics: Animals; Anisoles; Antineoplastic Agents; Buthionine Sulfoximine; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Ethacrynic Acid; Humans; In Vitro Techniques; Lomustine; Melanoma, Experimental; Melphalan; Mice; Monophenol Monooxygenase; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured | 1998 |
The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice.
Topics: Animals; Antineoplastic Agents; Autoradiography; Carbon Radioisotopes; Injections, Intravenous; Melanoma, Experimental; Mice; Nitrosourea Compounds; Organophosphorus Compounds; Tissue Distribution | 1990 |